123 related articles for article (PubMed ID: 12605893)
1. Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum.
Kotake Y; Ohta S; Kanazawa I; Sakurai M
Neuroscience; 2003; 117(1):63-70. PubMed ID: 12605893
[TBL] [Abstract][Full Text] [Related]
2. [Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances].
Kotake Y
Yakugaku Zasshi; 2002 Nov; 122(11):975-82. PubMed ID: 12440154
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
[TBL] [Abstract][Full Text] [Related]
4. Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats.
Lorenc-Koci E; Smiałowska M; Antkiewicz-Michaluk L; Gołembiowska K; Bajkowska M; Wolfarth S
Neuroscience; 2000; 95(4):1049-59. PubMed ID: 10682712
[TBL] [Abstract][Full Text] [Related]
5. Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum.
Lyng GD; Snyder-Keller A; Seegal RF
Toxicol Sci; 2007 May; 97(1):128-39. PubMed ID: 17324953
[TBL] [Abstract][Full Text] [Related]
6. Co-culture with the striatum attenuates N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of rat mesencephalic slice cultures.
Maeda T; Ibi M; Shimazu S; Akaike A
Jpn J Pharmacol; 1998 Jun; 77(2):161-7. PubMed ID: 9681573
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF.
Jaumotte JD; Zigmond MJ
Brain Res Mol Brain Res; 2005 Mar; 134(1):139-46. PubMed ID: 15790537
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.
Lyng GD; Snyder-Keller A; Seegal RF
Brain Res; 2007 Feb; 1133(1):1-9. PubMed ID: 17196555
[TBL] [Abstract][Full Text] [Related]
9. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
Nagatsu T; Yoshida M
Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
Wąsik A; Romańska I; Michaluk J; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
Neurotox Res; 2016 Apr; 29(3):351-63. PubMed ID: 26303030
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
Kotake Y; Taguchi R; Okuda K; Sekiya Y; Tasaki Y; Hirobe M; Ohta S
Brain Res; 2005 Feb; 1033(2):143-50. PubMed ID: 15694918
[TBL] [Abstract][Full Text] [Related]
12. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
Wąsik A; Romańska I; Antkiewicz-Michaluk L
Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
[TBL] [Abstract][Full Text] [Related]
14. Superoxide dismutase activity in organotypic midbrain-striatum co-cultures is associated with resistance of dopaminergic neurons to excitotoxicity.
Katsuki H; Tomita M; Takenaka C; Shirakawa H; Shimazu S; Ibi M; Kume T; Kaneko S; Akaike A
J Neurochem; 2001 Mar; 76(5):1336-45. PubMed ID: 11238718
[TBL] [Abstract][Full Text] [Related]
15. The influence of target and non-target brain regions on the development of mid-brain dopaminergic neurons in organotypic slice culture.
Holmes C; Jones SA; Greenfield SA
Brain Res Dev Brain Res; 1995 Sep; 88(2):212-9. PubMed ID: 8665668
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice.
Perry TL; Jones K; Hansen S
Neurosci Lett; 1988 Feb; 85(1):101-4. PubMed ID: 3362404
[TBL] [Abstract][Full Text] [Related]
17. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
18. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
